SUD 0.00% 4.2¢ suda pharmaceuticals ltd

announce what your sitting on, page-38

  1. 3,982 Posts.
    lightbulb Created with Sketch. 213
    clyde on the point of losing control didnt we have the same issue years ago  with losing control over clinical trial information on Artimist from ProtoPharma. I seem to recall reading it in annual reports for 2011 though to 2014. 

 
watchlist Created with Sketch. Add SUD (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.